Dr. Espaillat is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1800 Ridge Avenue
404
Evanston, IL 60201
Summary
- Dr. Espaillat was born and raised in New York City and graduated from the Pontificia Universidad Catolica Madre y Maestra in the Dominican Republic. He returned to New York to Bronx-Lebanon Medical Center to complete his Internal Medicine residency and board certification in Internal Medicine.
After 7 years in private practice in New York and Long Island specializing in cardiovascular and metabolic disease, Ramon joined Abbott in 2005 as a Senior Medical Liaison in the Cardiovascular Division. During his 6 years as an MSL, he worked extensively throughout Latina America developing educational and outreach programs with healthcare providers and institutions as well as gaining a second board certification in Clinical Lipidology. He also spent 6 months in Johannesburg as the interim Affiliate Medical Director for South Africa/Region Africa. With the birth of AbbVie in 2013, he became a Medical Director within Medical Affairs helping develop ongoing medical strategies and tactics to address unmet medical and patient needs.
Education & Training
BronxCare Health SystemResidency, Internal Medicine, 1996 - 1999
Pontificia Universidad Católica Madre y MaestraClass of 1994
Certifications & Licensure
NY State Medical License 1999 - 2026- American Board of Internal Medicine Internal Medicine
- National Lipid Association Clinical Lipidology Board
Publications & Presentations
PubMed
- A randomized phase 3b study evaluating the safety and efficacy of risankizumab in adult patients with moderate-to-severe plaque psoriasis with non-pustular palmoplanta...Mark Lebwohl, Michael Bukhalo, Linda Stein Gold, Brad Glick, Mar Llamas-Velasco
Journal of the American Academy of Dermatology. 2024-12-01 - A Descriptive, Post Hoc Analysis of Efficacy and Safety of Risankizumab in Diverse Racial and Ethnic Patient Populations With Moderate-to-Severe Psoriasis.Andrew F Alexis, Melinda Gooderham, Shawn G Kwatra, Ahmad Amin, Susan Taylor
Dermatology and Therapy. 2024-10-01 - Comparative Effectiveness of Persistent Use of a Name-Brand Levothyroxine (Synthroid®) vs. Persistent Use of Generic Levothyroxine on TSH Goal Achievement: A Retrospec...Liya Wang, Yaozhu J Chen, Michael Grabner, Bal Nepal, Amit Bodhani
Advances in Therapy. 2022-01-01
Professional Memberships
- Member
Other Languages
- Spanish, French, Portuguese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
